Sir, I read with interest the case report by Sharma et al. [1] on the primary Ewing's sarcoma (ES) of cranium in an Indian child. It is obvious that due to poor immunity, individuals infected with human immunodeficiency virus (HIV) are at increased risk to various neoplasms compared to the immunocompetent individuals. [2] To my knowledge, HIV infection is an important health threat in India. Although no recent data are present on the pediatric HIV seroprevalence, the available data pointed out to the substantial HIV seroprevalence rate of 1.03% among pregnant women in India. [3] Regrettably, the HIV status of the mother was unknown. I presume that some sort of vertical HIV transmission ought to be expected in the studied child. Hence, arrangement for the diagnostic set of CD4 count and viral overload estimations was envisaged in the studied child. If that diagnostic set was performed and it disclosed underlying HIV infection, the case in question could truly widen the spectrum of HIV-associated skeletal ES rarely reported in the literature. [4] Financial support and sponsorship Nil.
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. Dear Sir, We read with interest the article by Jauhari et al. [1] about a 21-month-old boy with Leigh syndrome due to the nDNA-variant c.131A>G in the PDHA1 gene who presented with regression of milestones, microcephaly, floppiness, failure to thrive, dysphagia, episodes of respiratory insufficiency, lactic acidosis, and relapses during infections, and responded favorably to thiamine. We have the following comments and concerns.
Because PDHA1-related Leigh syndrome is X-linked, it is conceivable that the mother of the index case is a manifesting carrier (two-thirds of the cases). Was the mother prospectively investigated for clinical or subclinical manifestations of PDH deficiency? Were there any indications that the disease was inherited from the mother's side? Was the further family history positive for PDH deficiency?
It is unclear what the authors mean with "episodes of encephalopathy." [1] Did the patient develop stroke-like episodes, which have been occasionally reported in PHD deficiency [2] and usually go along with typical morphological abnormalities on imaging, or do the authors simply mean the recurrent deteriorations triggered by infections? Were magnetic resonance imaging (MRI) and electroencephalogram (EEG) normal during these episodes? Which type of treatment did the patient receive for these conditions?
The patient died suddenly and unexpectedly. [1] Did he ever undergo long-term electrocardiogram Thiamin-Responsive PDH Deficiency due to a PDHA1 Variant
